Conference abstract · 23 Aug 2017
Conference abstractPublished 9 Nov 2017
BIOCHEMISTRY OF WOUND HEALING: FROM BENCH TO BED SIDE
University of Urbino, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Chronic venous diseases are widespread in Western countries, and their main complication (i.e., venous leg ulcer) is involved in more than half of lower extremity wounds, with prevalence up to 15% in the aged population; it represents a chronic recurrent problem inducing decreased quality of life as well increased morbidity and healthcare costs. The purpose of this study is to describe our experience in wound translational medicine, characterizing early biomolecular pathways of healing/non-healing processes and developing novel targeted therapies. Methodology & Theoretical Orientation: Based on the exhibition in chronic wounds of both inflammatory and proteolytic altered metabolisms, as well as extracellular and endothelial dysfunctions, we analyzed soluble and membrane-bound biomolecules released in venous leg ulcer fluids as a mirror of wound microenvironment in healing and non-healing phases, with and without pharmacologic treatments. Findings: The biochemical profiles (e.g., IL-1beta, CXC-8, VEGF, TGF-beta3, MMP-9 and MMP-12) in inflammatory wounds were found statistically different from those granulating ulcers, as well as significantly altered respect to plasma profiles. On the other hand, granulating healing wounds showed significantly increased levels of IP-10, CCL-5 and PDGF-bb. Finally, in vitro studies highlighted that pharmacologic treatments (e.g., glycosaminoglycan and flavonoid) significantly down regulated the release of peculiar soluble and membrane-bound inflammatory mediators (e.g. IL-12, VEGF, TNF-alfa, MMP-2 and TIMP). Conclusions: Our studies revealed different biochemical microenvironments in both non-healing and healing venous leg ulcers, pinpointing their role af inflammatory and proteolytic hallmarks in wound healing. Moreover, the ability of glycosaminoglycan to counteract the inflammatory and degradative processes in non-healing wound provides a biochemical tool for developing a targeted therapy.
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2023
Moisture matters in wound bed preparation & healing
Conference abstract · 2020
Bench to Bed - Molecular for COVID-19 Investigation
Conference abstract · 9 Nov 2017
STEM CELL DYNAMICS AND CELL PLASTICITY IN THE WOUND BED
Research article · 11 Jun 2026
Collagen Hydrolysates, from Beauty Supplements to Supporting Wound Healing: How Solid is the Rationale? An Overview and Insights for Regenerative Medicine Practitioners
More from this journal
The newest in Journal of Tissue Science and Engineering.
Brief report · 29 Dec 2025
Skin Tissue Engineering: Accelerating Wound Healing With Biomaterials
Opinion · 29 Dec 2025
Biomaterials, Cells, And Stimulation For Spinal Cord Repair
Brief report · 29 Dec 2025
Cardiac Tissue Engineering: Building a New Heart
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Tissue Science and Engineering
- SubjectEngineering
- BylineArticles whose byline prints “Ferdinando Mannello”
- BylineArticles whose byline prints “Daniela Ligi”
- BylineArticles whose byline prints “Lidia Croce”

